Akcea Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AKCA and buy or sell other stocks, ETFs, and their options commission-free!About AKCA
Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology.
CEODamien McDevitt, PhD
CEODamien McDevitt, PhD
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees—
Employees—
AKCA Key Statistics
Market cap1.85B
Market cap1.85B
Price-Earnings ratio-46.08
Price-Earnings ratio-46.08
Dividend yield—
Dividend yield—
Average volume476.70K
Average volume476.70K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$21.71
52 Week high$21.71
52 Week low$8.00
52 Week low$8.00
Stock Snapshot
Akcea Therapeutics(AKCA) stock is priced at $18.17, giving the company a market capitalization of 1.85B. It carries a P/E multiple of -46.08.
During the trading day, Akcea Therapeutics(AKCA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 476.7K.
Over the past 52 weeks, Akcea Therapeutics(AKCA) stock has traded between a high of $21.71 and a low of $8.00.
Over the past 52 weeks, Akcea Therapeutics(AKCA) stock has traded between a high of $21.71 and a low of $8.00.
People also own
Based on the portfolios of people who own AKCA. This list is generated using Robinhood data, and it’s not a recommendation.